A randomized clinical trial of ultrasound-guided double percutaneous needling versus high-energy extracorporeal shockwave therapy in the treatment of calcific tendinopathy of the rotator cuff. - nvt

Spaarne Ziekenhuis0 个研究点目标入组 100 人开始时间: 待定最近更新: 2024年4月29日

适应症

试验速览

暂无简介。

•Age > 18 years
•Clinical signs of subacromial impingement of the shoulder
•Symptoms persisting for more than four months
•Unsuccessful conservative therapy within the previous four months. (Physiotherapy, radiotherapy, infiltration with local anaesthetics and/or steroids, anti-inflammatory drugs)
•Standardised radiographs showing calcific deposits with a diameter of at least 5 mm. (Morphological type-I and type-II deposits corresponding to the classification of Gartner and Simons on radiographs: Type I, sharply outlined and densely structured. Type II, sharply outlined and inhomogenous or homogenous with no defined border)

•Evidence of full-thickness tears of the rotator cuff on physical examination, ultrasound images or MRI.
•Radiological signs of spontaneous resorption of the deposit and type-III deposits according to the classification of Gartner and Simons: Type III, cloudy and transparent in structure.
•Calcific deposits in multiple tendons of the rotator cuff.
•Acute subacromial/subdeltoid bursitis.
•Osteoarthritis of the glenohumeral or acromioclavicular joint.
•Previous surgery to the shoulder.
•Adhesive capsulitis
•Instability of the shoulder.
•ESWT / barbotage within the last year.
•Reumatoid arthritis.
•Neurological disorders or dysfunction of the upper limb.
•Heart pacemaker, pregnancy, infection, tumour, hypocoagulability.
•Unability to give informed consent.

发起方

Spaarne Ziekenhuis